New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+‐dependent anion leak

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Physiology

• Publication date

  2004-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1113/jphysiol.2004.062521PMID 15107471PMCID PMC1665628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Chloride Permeation Pathway of a Glutamate Transporter and Its Proximity to the Glutamate Translocation Pathway*

  2004influential reference
• Glutamate Modifies Ion Conduction and Voltage-dependent Gating of Excitatory Amino Acid Transporter-associated Anion Channels*

  2003influential reference
• Glutamine efflux from astrocytes is mediated by multiple pathways

  2003cited by this paper
• Regulation of the glutamine transporter SN1 by extracellular pH and intracellular sodium ions

  2002cited by this paper
• Comparison of Coupled and Uncoupled Currents during Glutamate Uptake by GLT-1 Transporters

  2002cited by this paper
• Na(+)-dependent neutral amino acid transporter ATB(0) is a rabbit epithelial cell brush-border protein.

  2001cited by this paper
• Recent molecular advances in mammalian glutamine transport.

  2001cited by this paper
• The anion conductance of the glutamate transporter EAAC1 depends on the direction of glutamate transport

  2001cited by this paper
• A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). new glutamate and aspartate analogues as potential neuroprotective agents.

  2001cited by this paper
• Early Intermediates in the Transport Cycle of the Neuronal Excitatory Amino Acid Carrier Eaac1

  2001cited by this paper
• Neutral amino acid transporter ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion conductance.

  2000influential reference
• Glutamate translocation of the neuronal glutamate transporter EAAC1 occurs within milliseconds.

  2000cited by this paper
• Arginine 447 Plays a Pivotal Role in Substrate Interactions in a Neuronal Glutamate Transporter*

  2000cited by this paper
• Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.

  1999cited by this paper
• The Astroglial ASCT2 Amino Acid Transporter as a Mediator of Glutamine Efflux

  1999influential reference
• Macroscopic and Microscopic Properties of a Cloned Glutamate Transporter/Chloride Channel

  1998cited by this paper
• Anion Currents and Predicted Glutamate Flux through a Neuronal Glutamate Transporter

  1998cited by this paper
• DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.

  1998influential reference
• An expression system for mammalian amino acid transporters using a stably maintained episomal vector.

  1997cited by this paper
• Ion Channels in Excitable Membranes

  1996influential reference
• Cloning and Functional Characterization of a System ASC-like Na+-dependent Neutral Amino Acid Transporter*

  1996influential reference
• Differential expression of three glutamate transporter subtypes in the rat retina

  1996cited by this paper
• ASCT-1 Is a Neutral Amino Acid Exchanger with Chloride Channel Activity*

  1996influential reference
• Ion fluxes associated with excitatory amino acid transport.

  1995cited by this paper
• Na(+)-coupled alanine transport in LLC-PK1 cells.

  1994cited by this paper
• Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

  1994cited by this paper
• Gene-product designations for amino acid transporters.

  1994cited by this paper
• Recent advances in mammalian amino acid transport.

  1993cited by this paper
• Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family.

  1993cited by this paper
• Cloning and expression of a novel Na(+)-dependent neutral amino acid transporter structurally related to mammalian Na+/glutamate cotransporters.

  1993cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987cited by this paper
• The transport of alanine, serine, and cysteine in cultured human fibroblasts.

  1982cited by this paper
• The A, ASC, and L systems for the transport of amino acids in Chinese hamster ovary cells (CHO-K1).

  1981cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Effect of substrate structure on coupling ratio for Na + -dependent transport of amino acids.

  1971cited by this paper

• Natural products targeting the metabolism of amino acids: from discovery to synthetic development.

  2025cites this paper
• A bacteria-based bioorthogonal platform disrupts the flexible lipid homeostasis for potent metabolic therapy

  2025cites this paper
• Targeting glutamine metabolism as a potential target for cancer treatment

  2025cites this paper
• Recent advances in ASCT2 inhibitors: ligand design and therapeutic applications.

  2025cites this paper
• Energy metabolism in health and diseases

  2025cites this paper
• Cooperative nutrient scavenging is an evolutionary advantage in cancer

  2025cites this paper
• Exploiting the Achilles’ heel of cancer: disrupting glutamine metabolism for effective cancer treatment

  2024cites this paper
• Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches

  2024cites this paper
• Comprehensive review of amino acid transporters as therapeutic targets.

  2024cites this paper
• Glutamine addiction in tumor cell: oncogene regulation and clinical treatment

  2024cites this paper
• Emerging roles of the chromatin remodeler MORC2 in cancer metabolism

  2024cites this paper
• Transient kinetics reveal the mechanism of competitive inhibition of the neutral amino acid transporter ASCT2

  2024cites this paper
• Discovery and Synthesis of Hydroxy-l-Proline Blockers of the Neutral Amino Acid Transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2)

  2024cites this paper
• SLC1 family of amino acid transporters in GtoPdb v.2023.1

  2023cites this paper
• Do Amino Acid Antiporters Have Asymmetric Substrate Specificity?

  2023cites this paper
• Impact of the polymer backbone chemistry on interactions of amino-acid-derived zwitterionic polymers with cells

  2023cites this paper
• Glutaminolysis and peripheral CD4+ T cell differentiation: from mechanism to intervention strategy

  2023cites this paper
• ASC Transporters Mediate D-Serine Transport into Astrocytes Adjacent to Synapses in the Mouse Brain

  2023cites this paper
• Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer

  2023cites this paper
• Zwitterionic Amino Acid-Derived Polyacrylates as Smart Materials Exhibiting Cellular Specificity and Therapeutic Activity.

  2022cites this paper
• Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis.

  2022cites this paper
• Structure and allosteric inhibition mechanism of excitatory amino acid transporter 1

  2022cites this paper
• Alanine serine cysteine transporter (ASCT) substrate binding site properties probed with hydroxyhomoserine esters.

  2022cites this paper
• The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake

  2022cites this paper
• Recent progress of amino acid transporters as a novel antitumor target

  2022cites this paper
• Conserved allosteric inhibition mechanism in SLC1 transporters

  2022cites this paper
• Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family

  2022influential citation
• Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)

  2022cites this paper
• Structural basis of ligand binding modes of human EAAT2

  2022cites this paper
• Targeting Energy Metabolism in Cancer Treatment

  2022influential citation
• Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells

  2022cites this paper
• The role of the glutamine transporter ASCT2 in antineoplastic therapy

  2021cites this paper
• Discovery and synthesis of hydroxy-L-proline based blockers of the neutral amino acid transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2)

  2021cites this paper
• Glutamine metabolism in prostate cancer

  2021cites this paper
• Rational design of ASCT2 inhibitors using an integrated experimental-computational approach

  2021influential citation
• ASCT1 and ASCT2: Brother and Sister?

  2021cites this paper
• ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation

  2021cites this paper
• Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How

  2020cites this paper
• Amino Acid Transporters and Exchangers from the SLC1A Family: Structure, Mechanism and Roles in Physiology and Cancer

  2020cites this paper
• A systems biology approach to cellular homeostasis, volume changes and regulation of metabolism

  2020cites this paper
• Interaction of the neutral amino acid transporter ASCT2 with basic amino acids.

  2020cites this paper
• Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and future for novel cancer therapy.

  2020cites this paper
• Glutamine reliance in cell metabolism

  2020cites this paper
• Oncology Therapeutics Targeting the Metabolism of Amino Acids

  2020influential citation
• Diseases & Disorders | Therapies Targeting Glutamine Addiction in Cancer

  2020cites this paper
• Structural basis for stereospecific inhibition of ASCT2 from rational design

  2020influential citation
• Revisiting prostate cancer metabolism: From metabolites to disease and therapy

  2020cites this paper
• Inhibition of glutamine metabolism as a therapeutic approach against pancreatic ductal adenocarcinoma

  2019cites this paper
• Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds

  2019cites this paper
• ASCT2: a potential cancer drug target

  2019cites this paper
• Genetically-encoded halide sensor-based fluorescent assay for rapid screening of glutamate transport and inhibition.

  2019cites this paper
• Warburg and Krebs and related effects in cancer

  2019cites this paper
• Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis

  2019cites this paper
• Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual Dysfunction

  2018cites this paper
• Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5

  2018cites this paper
• Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth

  2018cites this paper
• Mouse retinal pigment epithelial cells exhibit a thiocyanate-selective conductance.

  2018cites this paper
• Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways

  2018cites this paper
• The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology

  2018cites this paper
• Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods

  2018cites this paper
• Chapter 2 Amino Acid Transporters and Glutamine

  2018cites this paper
• Amino Acid Transporters as Disease Modifiers and Drug Targets

  2018cites this paper
• Characterization of the L-glutamate clearance pathways across the blood–brain barrier and the effect of astrocytes in an in vitro blood–brain barrier model

  2017influential citation
• Potential transfer of neurotoxic amino acid &bgr;‐N‐methylamino‐alanine (BMAA) from mother to infant during breast‐feeding: Predictions from human cell lines

  2017cites this paper
• Understanding the Regulation of the Human Amino Acid Transporter ASCT2

  2017influential citation
• Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2.

  2017cites this paper
• Ligand Discovery for the Nutrient Transporters ASCT2 and LAT‐1 from Homology Modeling and Virtual Screening

  2017cites this paper
• May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?

  2017cites this paper
• Engineering Tumour Cell-Binding Synthetic Polymers with Sensing Dense Transporters Associated with Aberrant Glutamine Metabolism

  2017cites this paper
• Structure and allosteric inhibition of excitatory amino acid transporter 1

  2017cites this paper
• Substrate and Cation Binding Mechanism of Glutamate Transporter Homologs

  2017cites this paper
• Phenylglycine analogs are inhibitors of the neutral amino acid transporters ASCT1 and ASCT2 and enhance NMDA receptor‐mediated LTP in rat visual cortex slices

  2017cites this paper
• Drug-induced amino acid deprivation as strategy for cancer therapy

  2017cites this paper
• Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells

  2016cites this paper
• From Krebs to clinic: glutamine metabolism to cancer therapy

  2016cites this paper
• From Krebs to clinic: glutamine metabolism to cancer therapy

  2016cites this paper
• Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells.

  2016influential citation
• D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures

  2016cites this paper
• The Glutamine Transporters and Their Role in the Glutamate/GABA-Glutamine Cycle.

  2016cites this paper
• Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells*

  2016cites this paper
• Enantioselective inhibition of d‐serine transport by (S)‐ketamine

  2015cites this paper
• Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening

  2015cites this paper
• Patch Clamp Analysis of Transporters Via Pre‐Steady‐State Kinetic Methods

  2015cites this paper
• Amino Acid Transporters and Glutamine

  2015influential citation
• 2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency.

  2015cites this paper
• Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development

  2015cites this paper
• Computational Studies of Glutamate Transporters

  2015cites this paper
• Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter

  2015cites this paper
• Na+ Interactions with the Neutral Amino Acid Transporter ASCT1*

  2014influential citation
• Targeting glutamine transport to suppress melanoma cell growth

  2014cites this paper
• Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health

  2014cites this paper
• A novel glutamate transporter blocker, LL-TBOA, attenuates ischaemic injury in the isolated, perfused rat heart despite low transporter levels.

  2014cites this paper
• Voltage-dependent processes in the electroneutral amino acid exchanger ASCT2

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: Transporters

  2013cites this paper
• Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.

  2013cites this paper
• In vivo D-serine hetero-exchange through alanine-serine-cysteine (ASC) transporters detected by microelectrode biosensors.

  2013cites this paper
• Anion Conducting States of Excitatory Amino Acid Transporters

  2013cites this paper
• GABA and Glutamate Transporters in Brain

  2013cites this paper
• Defining Substrate and Blocker Activity of Alanine-Serine-Cysteine Transporter 2 (ASCT2) Ligands with Novel Serine Analogs

  2012cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper